Biotech · Private company
Trishula Therapeutics, Inc.
Track this companyFree. Adds Trishula Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- Nab-Paclitaxel and gemcitabinePhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- TTX-030, budigalimab, nab-paclitaxel and gemcitabinePhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- TTX-030, nab-paclitaxel and gemcitabinePhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- nab paclitaxelPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TTX-030Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TTX-030 and budigalimabPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- TTX-030 and mFOLFOX6Phase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- TTX-030 and pembrolizumabPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- TTX-030, budigalimab and docetaxelPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- TTX-030, budigalimab and mFOLFOX6Phase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- TTX-030, budigalimab, nab-paclitaxel and gemcitabinePhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC PatientsPHASE2 · COMPLETED · started Mar 25, 2024ClinicalTrials.gov NCT06119217 · fetched Nov 12, 2026
- TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced CancersPHASE1 · COMPLETED · started Mar 30, 2020ClinicalTrials.gov NCT04306900 · fetched Nov 12, 2026
- TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced CancersPHASE1 · COMPLETED · started Apr 10, 2019ClinicalTrials.gov NCT03884556 · fetched Nov 12, 2026